Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

April 30, 2021
BioUtah News COVID-19 Updates Life Sciences Industry News Utah's Life Sciences Companies
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India

Co-Diagnostics’ Indian manufacturing facility, CoSara Diagnostics Pvt. Ltd. (“CoSara,” or the “JV”, a Joint Venture with Synbiotics Ltd) has been featured in recent press highlighting its actions to provide COVID-19 diagnostics as a surge of infections has led to the world’s worst COVID-19 outbreak since the pandemic began. The article in the Times of India […]

April 30, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
U.S. Study of DiscGenics IDCT Achieves One-Year Follow-Up Milestone

DiscGenics, a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine,  has completed enrollment in its Japanese safety study of Injectable Discogenic Cell Therapy (IDCT) for lumbar disc degeneration, a major cause of chronic low back pain. This Japanese 38-subject […]

April 30, 2021
Policy News
Biden’s First Address to Congress Calls for Giving Medicare Power to Negotiate Drug Prices

President Joe Biden’s first major joint address to Congress on Wednesday included calls to give Medicare the power to negotiate drug prices. “Let’s give Medicare the power to save hundreds of billions by negotiating lower prices… we pay the highest drug prices of anywhere in the world right here in America,” Biden said.  BioUtah and other […]

April 30, 2021
BioUtah News Utah's Life Sciences Companies
Canary Speech and Constant Companion Partner to Help Diagnose Behavioral Health Issues

Utah Business Magazine has highlighted a new partnership between Constant Companion and Canary Speech to study how voice technology can be used to identify human conditions in specific populations. Canary Speech will analyze the data with its patented speech digital biomarker technology, used to diagnose behavioral conditions and other diseases. Constant Companion will be utilizing its […]

April 30, 2021
BioUtah News COVID-19 Updates Utah's Life Sciences Companies
UNIVERSITY OF UTAH, ARUP, AND TECHCYTE DEVELOP NANOSPOT.AI, A NEW ULTRA-FAST TEST FOR COVID-19 ANTIBODIES

The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer COVID-19 antibody test. NanoSpot.AI is estimated to be significantly less expensive to manufacture than other antibody tests, so it has the potential to be much more affordable and extend […]

April 23, 2021
BioUtah News Policy News Press Releases
BioUtah Statement on House Democrat Leaders Drug Pricing Legislation

Salt Lake City, Utah (April 22, 2021) – BioUtah President and CEO, Kelvyn Cullimore, issued the following statement after House Democrat leaders released their drug pricing proposal, H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, based upon similar legislation introduced in the 116th Congress. “Utah has a long and proud history of […]

April 23, 2021
BioUtah News
Introducing the ReddyPortTM Microphone and Controller Technology Allowing Communication for Patients on Non- Invasive Ventilation

ReddyPort has launched the ReddyPortTM Microphone and Controller, a first-of-its-kind device that includes a single-patient use microphone which integrates withReddyPortTM Elbow, providing an interface for application of continuous positive airway pressure (CPAP) or bi-level therapy. ReddyPort Microphone and Controller is a proprietary system enabling clinicians and patients to communicate clearly with one another and their […]

April 23, 2021
Policy News
Life Sciences Company Valuation Webinar by Scalar & Now CFO

In case you missed the recent NOWCFO/Scalar webinar “What is Your Life Science or Bio Tech Company’s Worth?”, you can still pick up key takeaways from their informative power point. A successful life sciences company for sale can certainly be a hot commodity in today’s economy. Understanding your company’s value is vital to a lucrative […]

April 20, 2021
BioUtah News
Sumitomo Dainippon Pharma Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

CAMBRIDGE, Mass., April 10, 2021 — Sumitomo Dainippon Pharma Oncology, Inc., a clinicalstage company focused on research and development for novel cancer therapeutics, today presented new findings on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research (AACR) Virtual Annual Meeting I, taking place April 10-15, 2021. The […]

April 16, 2021
Policy News
President Biden Unveils Sweeping $2 Trillion Infrastructure Plan

On Wednesday, President Biden unveiled the first installment of his two-part Build Back Better plan – a sweeping $2.25 trillion infrastructure proposal billed as the American Jobs Plan.  In addition to fixing highways, bridges and roads, which accounts for approximately 5% of the plan ( $620 billion), the measure calls for a myriad of administration […]

April 16, 2021
Policy News
Study Analyzes Potential Impact of Drug Pricing Proposals

Congress is once again turning its attention to drug pricing, including the proposed use of foreign reference pricing models. Foreign reference pricing was part of the Lower Drug Costs Now Act passed by House Democrats in 2019 (also known as H.R. 3) and has resurfaced in legislation, the Prescription Drug Price Relief Act, recently introduced […]

April 16, 2021
Policy News
BioUtah Urges MCIT Implementation

BioUtah has submitted a comment letter to CMS in response to concerns raised by the Biden administration around the Medicare Coverage of Innovative Technology (MCIT) rule finalized under President Trump on January 14. The MCIT program was set to take effect on March 15, but on March 12, in the form of an interim final […]

April 16, 2021
BioUtah News
Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee

Fluidx’s regulatory and clinical affairs director will take the reins of the Regulatory, Compliance and Quality Committee, utilizing his expertise to help guide the regulatory and quality activities of BioUtah, the state’s premier life sciences trade association. Christopher Phillips, director of regulatory affairs and clinical affairs at Fluidx Medical Technology, has been appointed chair of […]

April 16, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
SDP Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new findings on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research (AACR) Virtual Annual Meeting I. The data presented at the meeting include preclinical and Phase 1 clinical data evaluating the potential anti-cancer activity of the PKM2 activator […]

April 16, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
PhotoPharmics Innovations Address Global Health Inequalities

PhotoPharmics has announced its intent to leverage its FDA breakthrough device designation, potential streamlined Medicare coverage under CMS’ pending Medicare Coverage of Innovative Technology (MCIT) rule and global delivery channels to deliver its treatments for Parkinson’s and neurodegenerative diseases to individuals regardless of their location or income. Innovation not only brings improved treatments to address […]

April 16, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Innovative Med Tech Startup Xenter Announces Company Launch

Xenter has announced its formal launch in Salt Lake City. Founded in 2020 by seasoned life sciences entrepreneur Richard J. Linder, Xenter is innovating new wireless technologies and techniques for the treatment of heart and vascular disease. The company’s next-generation devices will integrate functions that formerly required multiple costly devices. “We are bringing the world’s […]

April 16, 2021
BioUtah News Industry News Press Releases Utah's Life Sciences Companies
Utah’s Recursion Goes Public – Announces Pricing of IPO

Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class A common stock at a price to the public of $18.00 per share. Recursion is offering 24,242,424 shares of its Class A common stock. The gross proceeds from the offering are expected to be $436.4 million. The shares are expected to […]

April 9, 2021
BioUtah News
IONIQ Sciences Awarded Another Patent

IONIQ Sciences was awarded another patent for “an apparatus for providing information that is useful in the diagnosis of a malignant lung lesion.” IONIQ’s newest Notice of Allowance by the State Intellectual Property Office of the People’s Republic of China (SIPO) covers critical advancements and refinements to our proprietary algorithm, which calculates the likelihood a […]

April 9, 2021
BioUtah News Industry News Life Sciences Industry News Utah's Life Sciences Companies
IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee

IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee. Dr. Pollock is an award-winning surgical oncologist, extensively published physician- scientist, Professor Emeritus in the Department of Surgical Oncology at MD Anderson Cancer Center and currently the Director of The Ohio State University Comprehensive Cancer Center (OSUCCC). […]

April 9, 2021
Policy News
Impact of International Reference Pricing on Drug Innovation

Policymakers in Washington are considering plans to replace the current market-based system for pricing prescription medicines with a system based on foreign reference pricing. If enacted, this policy will import to the US price controls that foreign countries use to deny patients access to the newest cures and treatments. It could also impede innovation and […]

April 2, 2021
BioUtah News
The Element Awards 2021: LIfe Sciences Women in Business Honored

The St. George Area Chamber of Commerce hosted the First Annual Element Awards recognizing sixteen outstanding women of achievement in Washington County. The inaugural event was held March 26 at the Dixie Convention Center. These women, including women on the front lines of the life sciences, are building a legacy that future generations will emulate […]

March 19, 2021
BioUtah News
BioHive Spotlight: Jeffery Nelson, Nelson Labs

Nelson Labs started in Utah and has grown under the leadership of Jeffery Nelson, Chairman of Nelson Labs. BIoHive turns the spotlight on Jeffery in this video as he talks about the company, its contributions to the life sciences industry and what it means to be a part. of BioHive. Nelson is “helping those innovators, […]

March 19, 2021
BioUtah News COVID-19 Updates HHS/FDA & Other Regulatory Utah's Life Sciences Companies
FDA Permits Marketing of BioFire COVID-19 Diagnostic Test Using Traditional Premarket Review Process

On March 17, the FDA granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections. The diagnostic test, which had an Emergency […]

March 11, 2021
BioUtah News
Utah Legislature Appropriates $600,000 to support BioHive initiative

On the last day of the Utah legislative session, the legislature passed SB 2 “New Fiscal Year Supplemental Appropriations Act”.   Among the items funded was $600,000 to support the BioHive branding initiative.  In SB 3 entitled “Appropriations Adjustments” the language makes clear that the amount of the $600,000 to be released is dependent on 1:1 matching from […]

March 11, 2021
COVID-19 Legislation Federal News Policy News
President Biden Signs $1.9 Trillion COVID-19 Relief Bill

Yesterday, President Biden signed into law the American Rescue Plan (H.R. 1319), a $1.9 trillion COVID-19 relief package that Congress approved this week. On Wednesday, the House of Representatives approved the Senate-passed version of the bill by a vote of 220 to 211, with one Democrat joining all Republicans in voting against it. Rep. Jared […]

March 11, 2021
BioUtah News Utah's Life Sciences Companies
Utah’s Biomerics Announces Expansion of Texas, Costa Rica Operations

Biomerics, headquartered in Salt Lake City, and a leading mid-market medical device contract manufacturer, has announced it is expanding its manufacturing footprint in Athens, TX where Biomerics FMI is a vertically integrated high volume catheter development and manufacturing leader in the attractive PTA, Endourology, and Endoscopy markets. The Texas expansion totals 24,000 sq. ft. including […]

March 1, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
IONIQ Sciences Finalist in National ‘Buzz of BIO’ Awards

Utah’s own IONIQ Sciences was named a finalist for the prestigious ‘Buzz of BIO 2021’ award in the ‘Diagnostic and Beyond’ category. Although IONIQ did not win the category, being among the top finalists is a signiicant distinction. Placement was determined by companies receiving the most votes. “We’re on a mission to modernize cancer detection […]

March 1, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®

Co-Diagnostics has announced that laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorized Rapid Response COVID-19 Saliva Test, which uses Co-Diagnostics CoPrimer™ technology, is now available through Walgreens Find Care®, allowing consumers a convenient, non-invasive option for PCR-based COVID-19 testing from their own. Dwight Egan, Co-Diagnostics CEO, stated, “Co-Diagnostics is proud that our technology will be available […]

March 1, 2021
BioUtah News Life Sciences Industry News Press Releases State News Utah's Life Sciences Companies
The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease. The partnership intends to implement RenalytixAI’s in vitro diagnostic platform, KidneyIntelX, in combination with a range of advanced clinical management solutions […]

March 1, 2021
Policy News
BioUtah Recognizes Rare Disease Day

Today, BioUtah recognizes Rare Disease Day – its patients, families, healthcare providers, advocates, policymakers and drug manufacturers – all dedicated to making a difference in the fight against rare disease. Here in Utah, we are working closely with our partners in the rare disease community to raise awareness and harness resources to support the goal […]

March 1, 2021
BioUtah News Events Life Sciences Events
2021 BioHive Entrepreneur and Investor Life Sciences Summit BioHive, J.P. Morgan, Pitch Competition, Local, National Investors and More…

ICYMI If you missed the 2021 BioHive Entrepreneur and Investor Life Sciences (E&I) Summit or weren’t able to attend all the sessions, you can access the programming for a limited time. Registered attendees can access recorded sessions free of charge. Not already registered? You can register and access the program for $25. The 2021 E&I […]

March 1, 2021
BioUtah News Policy News
BioUtah Hosts LIfe Sciences Roundtable with Congressional Healthcare Leaders

BioUtah recently held a life sciences industry roundtable with Republican lawmakers in the U.S. House of Representatives who play a key role in shaping healthcare policy around the FDA, CMS, NIH and more. Lawmakers included our own Rep. John Curtis (R-UT) who now sits on the House Energy and Commerce (E&C) Committee and Subcommittee on […]